Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

被引：0
|
作者：
Liezl Channing
Edina Sinanovic
机构：
[1] University of Cape Town,Health Economics Unit, School of Public Health and Family Medicine, Faculty of Health Sciences
来源：
Cost Effectiveness and Resource Allocation | / 12卷
关键词：
Cost-effectiveness analysis; New TB vaccine; Markov modelling; Childhood TB; South Africa; Tuberculosis; BCG vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa
    Kim, Sun-Young
    Russell, Louise B.
    Park, Jeehyun
    Verani, Jennifer R.
    Madhi, Shabir A.
    Cutland, Clare L.
    Schrag, Stephanie J.
    Sinha, Anushua
    VACCINE, 2014, 32 (17) : 1954 - 1963
  • [22] Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India
    Rebecca C. Harris
    Matthew Quaife
    Chathika Weerasuriya
    Gabriela B. Gomez
    Tom Sumner
    Fiammetta Bozzani
    Richard G. White
    Nature Communications, 13
  • [23] COST-EFFECTIVENESS ANALYSIS OF A POTENTIAL VACCINE TO PREVENT COLONIZATION BY HELICOBACTER PYLORI IN THE SOUTH-EUROPEAN CONTEXT
    Arcos Machancoses, J., V
    Romero, M.
    Crehua Gaudiza, E.
    Martinez Costa, C.
    VALUE IN HEALTH, 2022, 25 (12) : S174 - S175
  • [24] Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis
    Brenner, Isaac Ravi
    Flanagan, Clare F.
    Penazzato, Martina
    Webb, Karen A.
    Horsfall, Stephanie B.
    Hyle, Emily P.
    Abrams, Elaine
    Bacha, Jason
    Neilan, Anne M.
    Collins, Intira Jeannie
    Desmonde, Sophie
    Crichton, Siobhan
    Davies, Mary-Ann
    Freedberg, Kenneth A.
    Ciaranello, Andrea L.
    LANCET GLOBAL HEALTH, 2024, 12 (12): : e2068 - e2079
  • [25] The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
    Dunning, Lorna
    Francke, Jordan A.
    Mallampati, Divya
    MacLean, Rachel L.
    Penazzato, Martina
    Hou, Taige
    Myer, Landon
    Abrams, Elaine J.
    Walensky, Rochelle P.
    Leroy, Valeriane
    Freedberg, Kenneth A.
    Ciaranello, Andrea
    PLOS MEDICINE, 2017, 14 (11)
  • [26] Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea
    Yun, Jae-Won
    Choi, Min Joo
    Shin, Gyeong-Seon
    Lim, Jae-Ok
    Noh, Ji Yun
    Kim, Yun-Kyung
    Song, Joon Young
    Kim, Woo Joo
    Choi, Sang-Eun
    Cheong, Hee Jin
    PLOS ONE, 2019, 14 (01):
  • [27] Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis
    Evans, Denise
    Hirasen, Kamban
    Ramushu, Clive
    Long, Lawrence
    Sinanovic, Edina
    Conradie, Francesca
    Howell, Pauline
    Padanilam, Xavier
    Ferreira, Hannetjie
    Variaiva, Ebrahim
    Rajaram, Shakira
    Gupta, Aastha
    Juneja, Sandeep
    Ndjeka, Norbert
    PLOS ONE, 2024, 19 (10):
  • [28] Financing and cost-effectiveness analysis of public-private partnerships: Provision of tuberculosis treatment of South Africa
    Sinanovic E.
    Kumaranayake L.
    Cost Effectiveness and Resource Allocation, 4 (1)
  • [29] The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa
    Sinanovic, Edina
    Moodley, Jennifer
    Barone, Mark A.
    Mall, Sumaya
    Cleary, Susan
    Harries, Jane
    VACCINE, 2009, 27 (44) : 6196 - 6202
  • [30] Cost-effectiveness of alternative polio immunization policies in South Africa
    Griffiths, UK
    Botham, L
    Schoub, BD
    VALUE IN HEALTH, 2005, 8 (06) : A131 - A131
12345